Literature DB >> 10452242

Peritoneal recurrence of colon cancer detected by positron emission tomography: report of a case.

S Yasuda1, H Makuuchi, S Sadahiro, M Mukai, H Ishida, N Tokunaga, T Kimura, T Tajima, A Shohtsu.   

Abstract

Increased glucose metabolism has been reported to occur in association with colorectal cancer. As positron emission tomography (PET) using [18F]fluorodeoxyglucose is able to depict hypermetabolic sites, it can therefore be used to detect colorectal cancer. A 69-year-old male patient with a recurrent solitary liver metastasis from colon cancer underwent whole-body PET which revealed high [18F]fluorodeoxyglucose uptake in the lesion. Furthermore, PET revealed peritoneal metastases that had not been detected by conventional imaging methods. Consequently, PET proved useful in helping us to avoid performing unnecessary treatment for the liver metastasis. Although it is uncertain whether early identification of recurrence can prolong survival, it may help to prevent unnecessary treatments being carried out. Thus, the application of PET in carefully selected patients could be beneficial to the management of recurrent colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452242     DOI: 10.1007/BF02482990

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  Staging recurrent metastatic colorectal carcinoma with PET.

Authors:  D Delbeke; J V Vitola; M P Sandler; R C Arildsen; T A Powers; J K Wright; W C Chapman; C W Pinson
Journal:  J Nucl Med       Date:  1997-08       Impact factor: 10.057

2.  Oxygen consumption and anaerobic glycolysis of human malignant and normal tissue.

Authors:  R A MACBETH; J G BEKESI
Journal:  Cancer Res       Date:  1962-02       Impact factor: 12.701

3.  Patterns of recurrence after curative resection of carcinoma of the colon and rectum.

Authors:  S Galandiuk; H S Wieand; C G Moertel; S S Cha; R J Fitzgibbons; J H Pemberton; B G Wolff
Journal:  Surg Gynecol Obstet       Date:  1992-01

4.  Cancer screening with whole-body 18F-fluorodeoxyglucose positron-emission tomography.

Authors:  S Yasuda; A Shohtsu
Journal:  Lancet       Date:  1997 Dec 20-27       Impact factor: 79.321

5.  Recurrence of colorectal tumors: PET evaluation.

Authors:  L G Strauss; J H Clorius; P Schlag; B Lehner; B Kimmig; R Engenhart; M Marin-Grez; F Helus; F Oberdorfer; P Schmidlin
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

Review 6.  Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda.

Authors:  R L Wahl; R A Hawkins; S M Larson; W R Hendee; R E Coleman; R W Holden; M P Frick; C Gatsonis; G S Brown; F Shtern
Journal:  Radiology       Date:  1994-12       Impact factor: 11.105

7.  Enzymology of human colon tumors.

Authors:  G Weber; M S Lui; E Takeda; J E Denton
Journal:  Life Sci       Date:  1980-09-01       Impact factor: 5.037

8.  Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity.

Authors:  K Ito; T Kato; T Ohta; M Tadokoro; T Yamada; M Ikeda; M Nishino; T Ishigaki; S Gambhir
Journal:  Eur J Nucl Med       Date:  1996-10

9.  Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case.

Authors:  S Yasuda; S Raja; K F Hubner
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

10.  Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.

Authors:  S S Gambhir; C K Hoh; M E Phelps; I Madar; J Maddahi
Journal:  J Nucl Med       Date:  1996-09       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.